Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The high levels of fatigue in stroke patients without neurological impairment suggest it has a central origin rather than being the result of increased physical effort required after stroke(Winward et al., 2009). Fatigue is different from post-stroke depression and the more serious stroke patients are more prone to fatigue(Windward et al., 2009).
Fatigue is one of the symptoms of qi deficiency,and Astragalus membranaceus is the most effective of all traditional Chinese medicine and can tonifying middle and tonify the original qi. Therefore, the aim of this study was to investigate the efficacy of Astragalus membranaceus on post-stroke fatigue.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Chinese Herb Astragalus membranaceus | Experimental |
| |
| Placebo | Placebo Comparator |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Chinese Herb Astragalus membranaceus | Drug | Astragalus membranaceus(AM)at a rate of 2.8g three times per day |
|
| Measure | Description | Time Frame |
|---|---|---|
| EORTC QLQ-C30 | 2 year(all patients) | |
| BFI-T score | 2 years(all patients) |
| Measure | Description | Time Frame |
|---|---|---|
| SF-36 score | 2 years(all patients) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Chung Hsiang Liu, MD. | Contact | 886-4-22052121 | 7635 | greengen@gmail.com |
| Name | Affiliation | Role |
|---|---|---|
| Chung Hsiang Liu, MD. | China Medical University Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| China Medical University Hospital | Recruiting | Taichung | Taiwan |
Not provided
Not provided
Not provided
Not provided
Not provided
| Placebo | Other | at a rate of 2.8g three times per day |
|
| ID | Term |
|---|---|
| D005221 | Fatigue |
| D020521 | Stroke |
| ID | Term |
|---|---|
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D002561 | Cerebrovascular Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided